Products

AG003QLL

Name: Flumequine
Brand: Angene Chemical
SKU: AG003QLL

42835-25-6 | Flumequine

Chemical structure of Flumequine, CAS 42835-25-6

AG003QLL

SDS

COA

Price

$0.00

Add to Cart

WARNING This product is not for human or veterinary use.

Request For Quotation

CAS Number	42835-25-6
Catalog Number	AG003QLL(AGN-PC-0WAMN8)
Chemical Name	Flumequine
EC Number	255-962-6
IUPAC Name	7-fluoro-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid
InChI	InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)
InChI Key	DPSPPJIUMHPXMA-UHFFFAOYSA-N
MDL Number	MFCD00079298
Molecular Formula	C14H12FNO3
Molecular Weight	261.2484
NSC Number	757806
SMILES	CC1CCC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2
Synonyms	Apurone, flumequine, R 802, R-802, flumequine, 42835-25-6, Flumigal, Apurone, 9-Fluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid, Flumequinum, Flumequino, Flumiquil, Flumisol, Imequyl, Flumix, R 802 (bactericide), Flumequinum [INN-Latin], Flumequino [INN-Spanish], HSDB 7034, R 802, EINECS 255-962-6, MLS000069546, CHEBI:85269, DPSPPJIUMHPXMA-UHFFFAOYSA-N, MFCD00079298, 9-fluoro-6,7-dihydro-5-methyl-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic acid, NCGC00018211-03, AK-27078, SMR000058826, 1H,5H-Benzo(ij)quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-5-methyl-1-oxo-, 9-Fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid, DSSTox_CID_25623, DSSTox_RID_81008, DSSTox_GSID_45623, Q-201123, 6,7-Dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-quinolizine-2-carboxylic acid, 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-5-methyl-1-oxo-, 9-Fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid, SR-01000000130, Fantacin, Flumequine [USAN:BAN:INN], Flumequine [USAN:INN:BAN], (RS)-9-Fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid, Prestwick_603, Apurone (TN), CAS-42835-25-6, Spectrum_000367, AC1L1FSH, Flumequine (USAN/INN), Opera_ID_1399, Prestwick0_000204, Prestwick1_000204, Prestwick2_000204, Prestwick3_000204, Spectrum2_001200, Spectrum3_001417, Spectrum4_000826, Spectrum5_001532, R-802, SCHEMBL49829, BSPBio_000187, BSPBio_003094, KBioGR_001371, KBioSS_000847, MLS001074120, DivK1c_000089, SPECTRUM1500992, SPBio_001279, SPBio_002108, BPBio1_000207, CHEMBL370252, DTXSID5045623, CHEBI:94431, CTK1D6186, HMS500E11, KBio1_000089, KBio2_000847, KBio2_003415, KBio2_005983, KBio3_002314, NINDS_000089, HMS1568J09, HMS1921O10, HMS2092O08, HMS2095J09, HMS2230F14, HMS3373O15, HMS3652K09, HMS3712J09, Pharmakon1600-01500992, EBD52299, HY-B0526, KS-00000G9K, Tox21_110840, ANW-59991, CCG-40315, GA3854, NSC757806, s3181, SBB012470, fluoro-methyl-oxo-[?]carboxylic acid, 6,7-dihydro-9-fluoro-5-methyl-1-oxo- 1H,5H-quinolizine-2-carboxylic acid, AKOS015904879, Tox21_110840_1, AC-1284, API0002722, CS-2747, DB08972, HS-0096, MCULE-1576355150, NSC-757806, IDI1_000089, NCGC00018211-02, NCGC00018211-04, NCGC00018211-05, NCGC00018211-06, NCGC00018211-10, NCGC00089803-02, NCGC00089803-03, NCGC00178300-01, NCGC00178300-02, AN-15109, BC204036, CC-28464, LS-40210, ST072199, SBI-0051623.P002, AB1009285, AX8130483, TR-016689, F0832, FT-0626439, ST24045868, SW196774-3, D02302, Flumequine, VETRANAL(TM), analytical standard, AB00052187_17, AB00052187_18, 835F256, C-16315, SR-01000000130-2, SR-01000000130-4, BRD-A69777949-001-05-1, BRD-A69777949-001-15-0, 1H-Benzimidazol-2-amine, 1-[(4-methylphenyl)sulfonyl]-, Flumequine, European Pharmacopoeia (EP) Reference Standard, 42835-25-6,143984-63-8,42835-68-7(sodiumsalt), 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-5-methyl-1-oxo, 1H,5H-Benzo[ij]quinolizine-2-carboxylicacid, 9-fluoro-6,7-dihydro-5-methyl-1-oxo-, 6,7Dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo[ij]-quinolizine-2-carboxylic acid, 9-Fluoro-1,5,6,7-tetrahydro-5-methyl-1-oxopyrido[3,2,1-ij]quinoline-2-carboxylic Acid, 7-fluoro-12-methyl-4-oxo-1-azatricyclo[7.3.1.0;{5,13}]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid, null, quinolone, UNII-UVG8VSP2SJ, (+/-)-Flumequine, UVG8VSP2SJ, C14H12FNO3, Flumequine, 98% - 1G 1g, CID3374, ML130, C14-H12-F-N-O3, C012976, FLM, 799264-47-4,

Complexity	462
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	261.08g/mol
Formal Charge	0
Heavy Atom Count	19
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	261.252g/mol
Monoisotopic Mass	261.08g/mol
Rotatable Bond Count	1
Topological Polar Surface Area	57.6A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	2.9

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited